Developing new antiviral medications
Official title: Task B23: Medicinal Chemistry and Problem Solving Synthesis for Antivirals
Funded at Southern Research Institute · NIH-11270744 · Data updated 2026-11-12
This study is all about finding and testing new antiviral medicines that could help people fight off infections, so if you're dealing with a tough illness, these new treatments might be available to help you in the future!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Southern Research Institute NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | September 27, 2021 |
| Project end | July 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $346,221 |
| NIH project number | 272201800006I-P00006-759302100001-1 |
| Project ID | NIH-11270744 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by viral infections or those at risk of contracting infectious diseases.
✕Less likely to help
Patients with non-viral infections or those not affected by infectious diseases may not benefit from this research.
What this research studies
This research focuses on creating and evaluating new antiviral drugs to combat infectious diseases caused by various pathogens. It involves planning and assessing the development of these therapeutics, identifying promising drug candidates, and conducting laboratory tests to ensure their safety and effectiveness. The research includes both in vitro (test tube) and in vivo (live organism) studies to understand how these drugs work and their potential impact on diseases. Patients may benefit from the eventual availability of new antiviral treatments that are more effective against current and emerging infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral medications that improve treatment options for patients with infectious diseases.
How similar studies have gone: Other research has shown success in developing antiviral agents using similar methodologies, indicating a promising approach to tackling infectious diseases.
Where this research is happening
-
Southern Research Institute
Birmingham, United States Active
Researchers
- Principal investigator: Augelli-Szafran, Dr. Corinne — Southern Research Institute
- Study coordinator: Augelli-Szafran, Dr. Corinne
Related research
Other NIH-funded projects on the same topics.
-
Biomedical research facility to accelerate human-relevant disease research
A new shared-use hub called THRIVE will give researchers easier access to human-relevant models and workflows to speed translational science.
-
Developing models to understand infectious diseases.
This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.
-
Developing models to understand infectious diseases.
This study is working on building models that mimic infectious diseases to help researchers find better treatments and vaccines, which could lead to improved options for patients dealing with these illnesses.
-
Understanding how long-acting Telacebec works in the body
This study is looking at how a new long-lasting HIV treatment called Telacebec works in the body using animal models, so we can learn more about its safety and effectiveness for people living with HIV in the future.
-
Creating new medications to reduce inflammation caused by arsenic exposure
This study is looking for new medicines that can help reduce inflammation caused by arsenic exposure, aiming to find safe and effective treatments for people who have been affected by it.
-
New treatments for cognitive issues in HIV patients
This study is looking at how a protein from the HIV virus affects thinking and behavior in people with HIV, and it aims to create new treatments that can help balance brain chemicals to improve mental function for those dealing with HIV-related cognitive issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.